BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 18161394)

  • 21. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
    Raebel MA; Delate T; Ellis JL; Bayliss EA
    Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit.
    Bayliss EA; Ellis JL; Delate T; Steiner JF; Raebel MA
    Med Care; 2010 Mar; 48(3):267-72. PubMed ID: 20125044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Who will be denied Medicare prescription drug subsidies because of the asset test?
    Rice T; Desmond K
    Am J Manag Care; 2006 Jan; 12(1):46-54. PubMed ID: 16402888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of disease-modifying agents among multiple sclerosis patients enrolled in medicare from 1995 to 2002 and the impact of medicare part D: analysis of claims data from the medicare current beneficiary survey.
    Lundy J; Craig BM
    Clin Ther; 2006 Jan; 28(1):140-5. PubMed ID: 16490588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?
    Atherly A; Dowd B
    Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit.
    Stuart B; Briesacher BA; Shea DG; Cooper B; Baysac FS; Limcangco MR
    Health Aff (Millwood); 2005; 24(4):1022-31. PubMed ID: 16012142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicare Part D--the sea of choices meets the donut hole.
    Flaer PJ; Dondériz A; Younis MZ
    J Health Care Finance; 2007; 34(1):1-7. PubMed ID: 18972980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
    Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.
    Yin W; Basu A; Zhang JX; Rabbani A; Meltzer DO; Alexander GC
    Ann Intern Med; 2008 Feb; 148(3):169-77. PubMed ID: 18180465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coverage for mental health treatment: do the gaps still persist?
    Zuvekas SH; Meyerhoefer CD
    J Ment Health Policy Econ; 2006 Sep; 9(3):155-63. PubMed ID: 17031020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should healthy Medicare beneficiaries postpone enrollment in Part D?
    Federowicz M
    Find Brief; 2008 Nov; 11(9):1-4. PubMed ID: 19035030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting demand among older adults for medication therapy management services.
    Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
    Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.